ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases—Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
Marinde J. G. Bond(Utrecht University), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Cornelis Verhoef(Erasmus MC Cancer Institute), John J. Hermans(Erasmus MC), Mike S.L. Liem(Medisch Spectrum Twente), Gijs A. Patijn(Isala), Cornelis J.A. Punt(Utrecht University), Wouter K. G. Leclercq(Radboud University Nijmegen), Michael F. Gerhards(Erasmus MC), Babette I Kuiper(Amsterdam Neuroscience), Krijn P. van Lienden(University of Amsterdam), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Joost M. Klaase(University Medical Center Groningen), Karen Bolhuis(The Netherlands Cancer Institute), Anne M. May(Utrecht University), Aysun Komurcu(Netherlands Comprehensive Cancer Organisation), Dirk J. Grünhagen(Erasmus MC), Arjen M. Rijken(Amphia Ziekenhuis), Johannes H.W. de Wilt(Radboud University Nijmegen), Ulf P. Neumann(RWTH Aachen University), Thomas van Gulik, Cornelis H.C. Dejong(Maastricht University), Martinus J. van Amerongen(Sint Maartenskliniek), Theo Ruers(The Netherlands Cancer Institute), Marc Engelbrecht(University of Amsterdam), I. Quintus Molenaar(University Medical Center Utrecht), Koert P. de Jong(University of Padua), Niels F.M. Kok(The Netherlands Cancer Institute), T. Chapelle(Antwerp University Hospital)
Cited by 1
Related Papers
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k